Tuesday, July 7, 2015

Cynapsus launches public offering, applies to dual-list on NASDAQ

Cynapsus launches public offering, applies to dual-list on NASDAQ

June 10, 2015 by · Leave a Comment 

Tweet Cynapsus Therapeutics (OTCQX:CYNAF; TSX:CTH) is offering to sell 4.5 million common shares in an underwritten public offering through a registration statement filed with the SEC. BofA Merrill Lynch is acting as sole book-running manager for the proposed offering, with Nomura as a lead manager, and Noble Life Science Partners as co-manager. Cynapsus also expects […]

Cynapsus files for NASDAQ listing, offering, stock rollback

Cynapsus files for NASDAQ listing, offering, stock rollback

May 15, 2015 by · Leave a Comment 

Tweet Cynapsus Therapeutics (OTCQX:CYNAF; TSX:CTH) has filed a registration statement with the SEC for a public offering of common stock in the U.S. and has filed an application to list on the NASDAQ Capital Market. The timing, number of shares and price per share of the proposed offering have not yet been determined. Cynapsus also […]

Vital Therapies Phase 3 trial hits enrolment target

Vital Therapies Phase 3 trial hits enrolment target

January 30, 2015 by · Leave a Comment 

Tweet Vital Therapies (NASDAQ:VTL) has reached the 200 subject enrollment target in VTI-208, its randomized, open-label Phase 3 clinical trial in alcohol induced liver decompensation. “Executing on VTI-208 has been our primary focus over the last two years at about 50 leading hospitals in the U.S., Europe and Australia,” Terry Winters, CEO and co-chairman, said […]

LED Medical’s meteoric rise in dental imaging

LED Medical’s meteoric rise in dental imaging

December 16, 2014 by · Leave a Comment 

Tweet With a growing portfolio of digital imaging technology products for the dental sector, LED Medical Diagnostics (OTCQX:LEDIF; TSX-V:LMD; FSE:LME) is positioned to become a leading player in the North American market. “We are in the right space at the right time,” CEO, Dr. David Gane, says in an interview with BioTuesdays.com. “There is an […]

Novadaq rings NASDAQ opening bell

Novadaq rings NASDAQ opening bell

May 31, 2013 by · Leave a Comment 

Tweet Novadaq Technologies (NASDAQ:NVDQ: TSX:NVD) president and CEO Arun Menawat rang the opening bell at the NASDAQ today to mark the company’s one-year anniversary of listing on the NASDAQ Global Market. Novadaq’s core SPY Imaging technology has been integrated into four commercial imaging systems: SPY Elite, PINPOINT, LUNA and FireFly. Each system has been specifically […]

BioLineRx pipeline returns to the winner’s circle

BioLineRx pipeline returns to the winner’s circle

April 30, 2013 by · Leave a Comment 

http://www.youtube.com/watch?v=GE9bX0zfyUA’]

Tweet After disappointing investors in March by terminating a Phase 2/3 clinical trial of an anti-psychotic drug candidate for the treatment of schizophrenia, BioLineRx (NASDAQ:BLRX; TASE:BLRX) bounced back in April, posting positive Phase 2a results with an oral treatment for inflammatory bowel disease (IBD). “BioLineRx is not a binary company, but has a broad and […]

D. Medical in worldwide OEM pact with Twobiens

D. Medical in worldwide OEM pact with Twobiens

May 14, 2012 by · Leave a Comment 

Tweet D. Medical Industries (NASDAQ, TASE:DMED) has entered into an original equipment manufacturer agreement with Twobiens, a leading South Korean supplier of diabetes treatment and drug delivery products, for the worldwide distribution of its Spring Universal Detach Detect Infusion Sets under Twobiens’ private label. The three-year agreement contains annual sales targets and minimum order quantities […]

D. Medical in strategic reorganization

D. Medical in strategic reorganization

March 22, 2012 by · Leave a Comment 

Tweet D. Medical Industries (NASDAQ, TASE:DMED) has initiated a strategic restructuring designed to focus its business on maximizing and realizing the value of the company’s novel technology and intellectual property by licensing and/or selling the technology, or part of it, to third parties. At the same time, D. Medical said it will continue to pursue […]

NASDAQ approves Novadaq listing

NASDAQ approves Novadaq listing

March 1, 2012 by · Leave a Comment 

Tweet The common shares of Novadaq Technologies (TSX:NDQ) have been approved for listing on the NASDAQ Global Market under the ticker symbol NVDQ, and the shares will begin trading today. “The United States represents the largest market opportunity for Novadaq’s products and as the awareness for SPY Imaging has grown, many in the U.S. have […]

TearLab to explore commercial partnership opportunities in Japan

TearLab to explore commercial partnership opportunities in Japan

February 23, 2012 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has entered into a consulting agreement with one of its directors, Dr. Adrienne Graves, who will oversee identifying and leading discussions with potential partners for the commercialization of the TearLab Osmolarity System in Japan. Dr. Graves has been a member of TearLab’s board since April 2005. She was CEO of Santen […]

Next Page »

Email Newsletters with Constant Contact
Google+